Alex Kelly

Alex Kelly Email and Phone Number

C-Suite Biopharmaceutical Executive | Finance | Corporate Affairs | Investor Relations | Communications Operations | M&A @ Precision BioSciences, Inc.
Alex Kelly's Location
Chapel Hill, North Carolina, United States, United States
About Alex Kelly

With a combined background in corporate affairs, communications, IR, integrations, M&A, and sales, I know how to lead teams, work fast, deliver value from deals, and create excitement for change! I have used compelling storytelling to influence key internal and external stakeholders, including investors, sell-side analysts, and credit rating agencies, in addition to leading award-winning investor relations teams and managing $100B in back-to-back and overlapping integrations for fast-moving, highly transactive global companies. With a trailblazer mentality, I thrive in white space opportunities where I can help companies be the first to break new ground. Crafting the Allergan Social Contract was very meaningful to me, to our employees, to our board of directors and to our stakeholders. It was the first articulation by a large biopharma company of our commitment to provide accessible and affordable medicines to patients. I’m all for authentic culture rather than building bureaucracy and silos, and the most rewarding experiences have involved working with teams to achieve unexpected success.Across the industry, I have broad advocacy experience with extensive participation on industry and nonprofit boards. Currently, I am a member and Vice Chair of the California Life Sciences Association, and past Treasurer. I have also served as Chair and Treasurer of the HealthCare Institute of NJ and as President of The Allergan Foundation. Specialties: Acquisition Integration, Investor Relations, Communications, Debt & Equity Offerings, Mergers & Acquisitions, IPO, Turnarounds, Crisis & Change Management, Deal & Non-Deal Roadshows, International Investing, Disease States & Therapies, Corporate Social Responsibility, Turnarounds

Alex Kelly's Current Company Details
Precision BioSciences, Inc.

Precision Biosciences, Inc.

View
C-Suite Biopharmaceutical Executive | Finance | Corporate Affairs | Investor Relations | Communications Operations | M&A
Alex Kelly Work Experience Details
  • Precision Biosciences, Inc.
    Chief Financial Officer
    Precision Biosciences, Inc. Jan 2021 - Present
    Durham, North Carolina, Us
  • Precision Biosciences, Inc.
    Chief Corporate Affairs Officer
    Precision Biosciences, Inc. Oct 2020 - May 2021
    Durham, North Carolina, Us
  • Allergan
    Executive Vp, Corporate Affairs & Chief Communications Officer
    Allergan 2015 - May 2020
    Dublin, Coolock, Ie
    Member of the executive leadership team that reshaped Allergan after a series of rapid and transformational transactions, including the acquisition by Actavis (while keeping the Allergan name). Established internal and external messaging to support transformations, including the sale of the generic business in 2015, a proposed (and withdrawn) merger with Pfizer in 2016, a restructuring in 2017, and the run up to the merger with AbbVie in 2019 and 2020. Partnered with the CEO to create Allergan’s Social Contract with Patients, the first commitment by a large biopharma company to provide accessible and affordable medicines. Orchestrated development of Allergan’s “Bold for Life” culture. Recruited, hired, and developed a new corporate affairs leadership team covering all communications, government affairs, and patient advocacy functions.
  • Allergan
    President, The Allergan Foundation
    Allergan 2015 - 2020
    Dublin, Coolock, Ie
    Made a lasting impact in the communities where Allergan colleagues live and work. Over its 21 year history, the Allergan Foundation awarded more than $115 million in charitable grants as of May 2020, including $50 million in donations over five years.
  • Actavis Plc (Now Allergan)
    Senior Vice President, Chief Integration Officer
    Actavis Plc (Now Allergan) 2014 - 2015
    Dublin, Ie
    Reported to Chief Operating Officer. Promoted as Actavis acquired Forest Laboratories to lead integration efforts and pivoted quickly to planning the integration of Allergan. Managed the complexity of multiple integrations while delivering more than $2.8B in synergies. Managed integration for the $28B acquisition of Forest Labs (announced in February 2014 and closed in July 2014), as well as the $70B Allergan acquisition (announced in November 2014 and closed in March 2015). Beat the three-year Forest synergy target of $1B within nine months. Exceeded Allergan synergy target of $1.8B in 12 months.
  • Forest Labs
    Sr. Vice President, Chief Communications Officer, Public Affairs And Investor Relations
    Forest Labs 2013 - 2014
    Recruited by and reported to CEO to build a respected, consolidated corporate communications and investor relations team within an organization that had traditionally downplayed external communications. Recruited a six-person team from within the company to align resources to support public relations, corporate communications, internal communications, and investor relations initiatives. Led integration of Forest’s $2.9B acquisition of Aptalis Pharma, a privately-held (TPG) maker of gastrointestinal and cystic fibrosis drugs (in February 2014) to significantly expanded Forest’s GI portfolio and increase its international footprint.
  • Bausch + Lomb
    Vice President, Investor Relations
    Bausch + Lomb May 2013 - Aug 2013
    Bridgewater, Nj, Us
    Recruited to lead investor relations leading into B+L’s IPO (canceled within weeks when the Valeant deal was announced).
  • Merck
    Senior Vice President, Investor Relations
    Merck 2009 - 2013
    Rahway, New Jersey, Us
    Assumed leadership of an investor relations team that had struggled to gain credibility with investors and analysts in the years after the company recalled Vioxx (leading to lawsuits, lost revenue, and major restructurings). Team received recognition by Institutional Investor for having the Best IR Program in Pharma in 2011 as a result of counseling management to execute shareholder friendly actions, including the first dividend increase in seven years and a $15B share buy-back, and focusing investors on the value of the research pipeline.
  • Schering-Plough
    Group Vp, Global Communications And Investor Relations
    Schering-Plough 2007 - 2009
    Recruited by CEO (former CEO at Pharmacia) to lead global IR team support the turnaround of a business that had recently suffered from declining sales, manufacturing consent decree, legal challenges, and significant fines related to a Reg FD settlement in 2003. Member of the operations leadership team. Assumed leadership of the global IR team, adding Global Communications functions after the acquisition of Organon BioSciences (OBS) in 2007. Reported to CFO and to General Counsel.
  • Schering-Plough
    Vp, Investor Relations
    Schering-Plough 2004 - 2007
  • Novartis
    Executive Director, Investor Relations
    Novartis 2003 - 2004
    Basel, Baselstadt, Ch
    Recruited to lead US IR team. Served a six-month rotation at the company headquarters in Switzerland to gain familiarity with company leadership and more intimate knowledge of international investors. Worked on team to showcase the newly created $10B Sandoz generics business. Developed materials for analyst meeting to put a spotlight on the branded R&D pipeline.
  • Pharmacia
    Sr. Director, Investor Relations
    Pharmacia 2002 - 2003
    Recruited from field sales force due to exceptional drug and disease state knowledge needed to highlight competitive position and respond to investor/analyst questions. Developed deeper expertise from key internal relationships with R&D and commercial teams. Promoted twice in three years. Led day-to-day communications with investors and analysts.
  • Pharmacia & Upjohn
    Director, Investor Relations
    Pharmacia & Upjohn 1999 - 2002
  • Pharmacia & Upjohn
    District Sales Manager
    Pharmacia & Upjohn 1996 - 1999
    Promoted from Critical Care sales to District Sales Manager. Led 12 representatives selling CNS, diabetes, women's health, oncology, urology, and eye care products.
  • The Upjohn Company
    Pharmaceutical Sales Representative
    The Upjohn Company 1989 - 1996
    Primary Care Sales RepresentativeHospital Sales RepresentativeCritical Care Sales Specialist

Alex Kelly Skills

Investor Relations Pharmaceutical Industry Leadership Mergers And Acquisitions Cross Functional Team Leadership Strategy Executive Management Biotechnology Corporate Communications Communication Training Crisis Management Strategic Communications Product Launch Pharmaceutical Sales Competitive Analysis Acquisition Integration Marketing Strategy Competitive Intelligence Crisis Communications Equities Investments Life Sciences Marketing Communications Global Marketing Hospital Sales Tree House Building Strategic Partnerships Career Development Coaching Internal Communications Lifesciences Corporate Branding Mergers

Alex Kelly Education Details

  • Purdue University
    Purdue University
    Pharmacy

Frequently Asked Questions about Alex Kelly

What company does Alex Kelly work for?

Alex Kelly works for Precision Biosciences, Inc.

What is Alex Kelly's role at the current company?

Alex Kelly's current role is C-Suite Biopharmaceutical Executive | Finance | Corporate Affairs | Investor Relations | Communications Operations | M&A.

What is Alex Kelly's email address?

Alex Kelly's email address is ke****@****gan.com

What is Alex Kelly's direct phone number?

Alex Kelly's direct phone number is (908)-298*****

What schools did Alex Kelly attend?

Alex Kelly attended Purdue University.

What skills is Alex Kelly known for?

Alex Kelly has skills like Investor Relations, Pharmaceutical Industry, Leadership, Mergers And Acquisitions, Cross Functional Team Leadership, Strategy, Executive Management, Biotechnology, Corporate Communications, Communication Training, Crisis Management, Strategic Communications.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.